001     1024832
005     20250203103156.0
024 7 _ |a 10.1002/alz.065384
|2 doi
024 7 _ |a 1552-5260
|2 ISSN
024 7 _ |a 1552-5279
|2 ISSN
024 7 _ |a 10.34734/FZJ-2024-02498
|2 datacite_doi
037 _ _ |a FZJ-2024-02498
082 _ _ |a 610
100 1 _ |a Doering, Elena
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a The Link between Brain age and Alzheimer’s Disease development using different neuroimaging modalities
260 _ _ |a Hoboken, NJ
|c 2023
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1712670421_18043
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Brain age (BA) provides a proxy of general brain health through the prediction of chronological age (CA) from neuroimaging data of healthy individuals. During aging, the adult brain undergoes changes both on the morphological and metabolic level. Here, we compare the link between BA predicted from morphology (structural MRI) or metabolism (18F-FDG-PET) and cognitive function, as well as pathophysiological measures of Alzheimer’s disease (AD) in cognitively normal individuals (CN) and patients with mild cognitive impairment (MCI).
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 0
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Antonopoulos, Georgios
|0 P:(DE-Juel1)180946
|b 1
|u fzj
700 1 _ |a Hönig, Merle C.
|0 P:(DE-Juel1)178642
|b 2
|u fzj
700 1 _ |a van Eimeren, Thilo
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Eickhoff, Simon B.
|0 P:(DE-Juel1)131678
|b 4
|u fzj
700 1 _ |a Patil, Kaustubh
|0 P:(DE-Juel1)172843
|b 5
|u fzj
700 1 _ |a Drzezga, Alexander
|0 P:(DE-Juel1)177611
|b 6
|u fzj
773 _ _ |a 10.1002/alz.065384
|g Vol. 19, no. S3, p. e065384
|0 PERI:(DE-600)2201940-6
|n S3
|p e065384
|t Alzheimer's and dementia
|v 19
|y 2023
|x 1552-5260
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/1024832/files/Alzheimer%20s%20Dementia%20-%202023%20-%20Doering%20-%20The%20Link%20between%20Brain%20age%20and%20Alzheimer%20s%20Disease%20development%20using%20different.pdf
856 4 _ |y OpenAccess
|x icon
|u https://juser.fz-juelich.de/record/1024832/files/Alzheimer%20s%20Dementia%20-%202023%20-%20Doering%20-%20The%20Link%20between%20Brain%20age%20and%20Alzheimer%20s%20Disease%20development%20using%20different.gif?subformat=icon
856 4 _ |y OpenAccess
|x icon-1440
|u https://juser.fz-juelich.de/record/1024832/files/Alzheimer%20s%20Dementia%20-%202023%20-%20Doering%20-%20The%20Link%20between%20Brain%20age%20and%20Alzheimer%20s%20Disease%20development%20using%20different.jpg?subformat=icon-1440
856 4 _ |y OpenAccess
|x icon-180
|u https://juser.fz-juelich.de/record/1024832/files/Alzheimer%20s%20Dementia%20-%202023%20-%20Doering%20-%20The%20Link%20between%20Brain%20age%20and%20Alzheimer%20s%20Disease%20development%20using%20different.jpg?subformat=icon-180
856 4 _ |y OpenAccess
|x icon-640
|u https://juser.fz-juelich.de/record/1024832/files/Alzheimer%20s%20Dementia%20-%202023%20-%20Doering%20-%20The%20Link%20between%20Brain%20age%20and%20Alzheimer%20s%20Disease%20development%20using%20different.jpg?subformat=icon-640
909 C O |o oai:juser.fz-juelich.de:1024832
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a German Center for Neurodegenerative Diseases (DZNE), Bonn/Cologne, Germany.
|0 I:(DE-HGF)0
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)180946
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)178642
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131678
910 1 _ |a HHU Düsseldorf
|0 I:(DE-HGF)0
|b 4
|6 P:(DE-Juel1)131678
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)172843
910 1 _ |a HHU Düsseldorf
|0 I:(DE-HGF)0
|b 5
|6 P:(DE-Juel1)172843
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)177611
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 1
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-10-25
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
920 1 _ |0 I:(DE-Juel1)INM-7-20090406
|k INM-7
|l Gehirn & Verhalten
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-7-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21